BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25092823)

  • 1. Infection dynamics of sylvatic dengue virus in a natural primate host, the African Green Monkey.
    Hanley KA; Guerbois M; Kautz TF; Brown M; Whitehead SS; Weaver SC; Vasilakis N; Marx PA
    Am J Trop Med Hyg; 2014 Oct; 91(4):672-6. PubMed ID: 25092823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence for sylvatic cycles of chikungunya, dengue and Zika viruses in African green monkeys (Chlorocebus aethiops sabaeus) on St. Kitts, West Indies.
    Valentine MJ; Ciraola B; Aliota MT; Vandenplas M; Marchi S; Tenebray B; Leparc-Goffart I; Gallagher CA; Beierschmitt A; Corey T; Dore KM; de Lamballerie X; Wang C; Murdock CC; Kelly PJ
    Parasit Vectors; 2020 Oct; 13(1):540. PubMed ID: 33126907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live attenuated tetravalent dengue virus host range vaccine is immunogenic in African green monkeys following a single vaccination.
    Briggs CM; Smith KM; Piper A; Huitt E; Spears CJ; Quiles M; Ribeiro M; Thomas ME; Brown DT; Hernandez R
    J Virol; 2014 Jun; 88(12):6729-42. PubMed ID: 24696467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural infection of cynomolgus monkeys with dengue virus occurs in epidemic cycles in the Philippines.
    Kato F; Ishida Y; Kawagishi T; Kobayashi T; Hishiki T; Miura T; Igarashi T
    J Gen Virol; 2013 Oct; 94(Pt 10):2202-2207. PubMed ID: 23851439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic relationships between sylvatic and endemic dengue viruses.
    Vasilakis N; Durbin AP; da Rosa AP; Munoz-Jordan JL; Tesh RB; Weaver SC
    Am J Trop Med Hyg; 2008 Jul; 79(1):128-32. PubMed ID: 18606776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and phenotypic characterization of sylvatic dengue virus type 4 strains.
    Rossi SL; Nasar F; Cardosa J; Mayer SV; Tesh RB; Hanley KA; Weaver SC; Vasilakis N
    Virology; 2012 Feb; 423(1):58-67. PubMed ID: 22178263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine.
    Galula JU; Shen WF; Chuang ST; Chang GJ; Chao DY
    J Virol; 2014 Sep; 88(18):10813-30. PubMed ID: 25008922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains.
    Vasilakis N; Fokam EB; Hanson CT; Weinberg E; Sall AA; Whitehead SS; Hanley KA; Weaver SC
    Virology; 2008 Aug; 377(2):296-307. PubMed ID: 18570968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mosquitoes infected with dengue viruses in Brazil.
    de Figueiredo ML; de C Gomes A; Amarilla AA; de S Leandro A; de S Orrico A; de Araujo RF; do S M Castro J; Durigon EL; Aquino VH; Figueiredo LT
    Virol J; 2010 Jul; 7():152. PubMed ID: 20624314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes.
    Ito M; Katakai Y; Ono F; Akari H; Mukai RZ; Takasaki T; Kotaki A; Kurane I
    Arch Virol; 2011 Jun; 156(6):1073-7. PubMed ID: 21409446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
    Nivarthi UK; Kose N; Sapparapu G; Widman D; Gallichotte E; Pfaff JM; Doranz BJ; Weiskopf D; Sette A; Durbin AP; Whitehead SS; Baric R; Crowe JE; de Silva AM
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health.
    Vasilakis N; Cardosa J; Hanley KA; Holmes EC; Weaver SC
    Nat Rev Microbiol; 2011 Jun; 9(7):532-41. PubMed ID: 21666708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity.
    Durbin AP; Mayer SV; Rossi SL; Amaya-Larios IY; Ramos-Castaneda J; Eong Ooi E; Jane Cardosa M; Munoz-Jordan JL; Tesh RB; Messer WB; Weaver SC; Vasilakis N
    Virology; 2013 Apr; 439(1):34-41. PubMed ID: 23485373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of dengue and chikungunya virus strains circulating in New Delhi, India.
    Afreen N; Deeba F; Khan WH; Haider SH; Kazim SN; Ishrat R; Naqvi IH; Shareef MY; Broor S; Ahmed A; Parveen S
    Microbiol Immunol; 2014 Dec; 58(12):688-96. PubMed ID: 25346397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2.
    Gil L; Marcos E; Izquierdo A; Lazo L; Valdés I; Ambala P; Ochola L; Hitler R; Suzarte E; Álvarez M; Kimiti P; Ndung'u J; Kariuki T; Guzmán MG; Guillén G; Hermida L
    Immunol Cell Biol; 2015 Jan; 93(1):57-66. PubMed ID: 25178969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could an experimental dengue virus infection fail to induce solid immunity against homologous viral challenge in non-human primates?
    Valdés I; Gil L; Lazo L; Marcos E; Martín J; Suzarte E; Castro J; Romero Y; Guillén G; Hermida L
    Arch Virol; 2016 Feb; 161(2):465-70. PubMed ID: 26590068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of sylvatic and domestic African mosquito species in dengue emergence.
    Diallo M; Sall AA; Moncayo AC; Ba Y; Fernandez Z; Ortiz D; Coffey LL; Mathiot C; Tesh RB; Weaver SC
    Am J Trop Med Hyg; 2005 Aug; 73(2):445-9. PubMed ID: 16103619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of serum neutralizing antibody response in patients with primary dengue virus type 1 infection].
    Hu D; Li J; Wang D; DI B; Qiu L; Wang Y; Ding X; Che X
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1773-6, 1791. PubMed ID: 23268408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abundance and distribution of sylvatic dengue virus vectors in three different land cover types in Sarawak, Malaysian Borneo.
    Young KI; Mundis S; Widen SG; Wood TG; Tesh RB; Cardosa J; Vasilakis N; Perera D; Hanley KA
    Parasit Vectors; 2017 Aug; 10(1):406. PubMed ID: 28859676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.